Guillaume Blache
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Guillaume Blache has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Camille Jauffret
Department of Surgical Oncology, Institut Paoli-Calmettes, Marseille, France
3 shared publications - Gilles Houvenaeghel
Department of Gynecology, Hopital Européen
3 shared publications - Eric Lambaudie
Department of Surgical Oncology, Institut Paoli Calmettes, Marseille, France
2 shared publications - Laura Sabiani
Institut Paoli Calmettes, Department of Surgical Oncology, Marseille, France
2 shared publications - Alexandre de Nonneville
Aix-Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, Department of Medical Oncology, CRCM, Marseille, France
1 shared publication - Djamel Mokart
Department of Anesthesiology and Critical Care, Paoli-Calmettes Institute, Marseille, France
1 shared publication
Latest Publications
- Open Access
- 1 January 2022
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 33 (3)
Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes
Houvenaeghel G, et al. J Gynecol Oncol. 2022 Feb;33:e31. https://doi.org/10.3802/jgo.2022.33.e31
- 1 January 2022
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 33 (3)
Open AccessPosterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes
Houvenaeghel G, et al. J Gynecol Oncol. 2022 Feb;33:e31. https://doi.org/10.3802/jgo.2022.33.e31
- Open Access
- 1 January 2021
- Published by Fortune Journals in Journal of Surgery and Research
- Vol. 04 (02) , 218-228
Comparison with 2019 of breast surgery activity and breast cancer prognostic factors in a French cancer center during the first 6 months of the COVID-19 pandemic
Introduction The rapid spread of the COVID-19 pandemic left departments of surgery, especially in oncology unprepared. The diagnostic and therapeutic management of breast cancer in Paoli Calmettes Institute cancer center underwent a major reorganization. Methods This study aimed to describe whether there was a change in the rate of surgical activity and type of tumors treated since the beginning of the outbreak (year 2020 was divided into 3 periods: before March the 17th = P1, between March the 17th and May the 11th = P2, from May the 11th to July 31st = P3) and compared to 2019. Results Over the three periods, a 12.71% decrease in the overall breast cancer surgery activity (n = 967 vs 1062) and a 18.05% decrease in new breast cancer surgery (n = 709 vs 581) was observed. The second period (P2) was the most critical one in both situations. During P2 a higher rate of large tumors, grade SBR 3 and negative endocrine receptor tumors were observed, there was also fewer Luminal A-like histological type diagnosed , during P3 fewer cT0 tumors and finally during both P2 and P3 there was a higher rate of neo-adjuvant chemotherapy. Conclusion This challenging period led to the diagnosis of higher stage and more aggressive histological types of breast cancers subsequently leading to more aggressive treatments.
- 1 January 2021
- Published by Fortune Journals in Journal of Surgery and Research
- Vol. 04 (02) , 218-228
Open AccessComparison with 2019 of breast surgery activity and breast cancer prognostic factors in a French cancer center during the first 6 months of the COVID-19 pandemic
Introduction The rapid spread of the COVID-19 pandemic left departments of surgery, especially in oncology unprepared. The diagnostic and therapeutic management of breast cancer in Paoli Calmettes Institute cancer center underwent a major reorganization. Methods This study aimed to describe whether there was a change in the rate of surgical activity and type of tumors treated since the beginning of the outbreak (year 2020 was divided into 3 periods: before March the 17th = P1, between March the 17th and May the 11th = P2, from May the 11th to July 31st = P3) and compared to 2019. Results Over the three periods, a 12.71% decrease in the overall breast cancer surgery activity (n = 967 vs 1062) and a 18.05% decrease in new breast cancer surgery (n = 709 vs 581) was observed. The second period (P2) was the most critical one in both situations. During P2 a higher rate of large tumors, grade SBR 3 and negative endocrine receptor tumors were observed, there was also fewer Luminal A-like histological type diagnosed , during P3 fewer cT0 tumors and finally during both P2 and P3 there was a higher rate of neo-adjuvant chemotherapy. Conclusion This challenging period led to the diagnosis of higher stage and more aggressive histological types of breast cancers subsequently leading to more aggressive treatments.
- Open Access
- 1 January 2019
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 30 (5) , e74
Transperitoneal para-aortic lymphadenectomy by robot assisted laparoscopy in 10 steps
Heinemann M, et al. J Gynecol Oncol. 2018 Aug;30:e74. https://doi.org/10.3802/jgo.2019.30.e74
- 1 January 2019
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 30 (5) , e74
Open AccessTransperitoneal para-aortic lymphadenectomy by robot assisted laparoscopy in 10 steps
Heinemann M, et al. J Gynecol Oncol. 2018 Aug;30:e74. https://doi.org/10.3802/jgo.2019.30.e74